The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
A funding to expand operations and provide better patient care
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Subscribe To Our Newsletter & Stay Updated
